Insight Molecular Diagnostics Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.1 | $1.9 | $1.5 | $1.0 | $2.2 |
| Operating income | -$51.1 | -$61.0 | -$25.1 | -$18.0 | -$53.7 |
| Net income | -$50.2 | -$60.7 | -$27.8 | -$72.9 | -$64.1 |
| Cash Flow Statement | |||||
| Free cash flow | -$25.4 | -$21.2 | -$23.6 | -$49.9 | -$38.2 |
Shares outstanding 32.3M
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.